E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo.

Abstract
Background: The prediabetic state with impaired fasting glucose level (IFG) is one of the risk factors for endothelial dysfunction leading to atherosclerosis. Pulse wave velocity is an effective index of arterial stiffness and is widely used for noninvasive assessment of atherosclerosis.

Aims and Objectives: To assess the usefulness of pulse wave velocity (PWV) as an indicator of atherosclerosis in IFG. Also to compare PWV values in subjects with IFG and those with normal fasting glucose (NFG) levels and to correlate the PWV values with the fasting glucose levels.

Materials and Methods: Two hundred male subjects were involved in the study. Group 1 comprised subjects with IFG (n = 100). Group 2 comprised subjects with NFG (n = 100). Both the groups were evaluated for physiological parameters-Blood pressure and brachial-ankle pulse wave velocity (ba-PWV) using PeriScope. The biochemical parameters such as fasting blood glucose, HbA1c, and lipid profile were also measured. Statistical analysis was done using SPSS-19 software. All parameters were compared using unpaired Student’s t-test. Pearson correlation analysis was done to establish the relationship between two variables.

Results: Significant differences were found between the ba-PWV values in the IFG and NFG groups (1549.5 ± 60.5 cm/s vs 1351.7 ± 44.0 cm/s, p < 0.05). There was also significant positive correlation (r = 0.88) between ba-PWV value and fasting glucose level. The multiple regression analysis showed that IFG level is an independent risk factor for increased ba-PWV levels.

Conclusion: Our study showed that ba-PWV can be used as an indicator to detect the early development of atherosclerosis in subjects with IFG levels.

Key words: Pulse wave velocity, Atherosclerosis, Impaired fasting glucose, Arterial stiffness


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Hemamalini Ramasamy Vajravelu
Articles by Arpita Priyadarshini
Articles by Prabhavathi Krishnan
Articles by Saravanan Ayyavoo
on Google
on Google Scholar


REFERENCES
1. Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999-2000. Morb Mortal Wkly Rep. 2003;52:8337.
2. Davidson MB, Landsman PB, Alexander CM. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003;26:3329-30. [DOI via Crossref]    [Pubmed]   
3. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708-23. [DOI via Crossref]    [Pubmed]   
4. De Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn study. JAMA. 2001;285:2109-13. [DOI via Crossref]    [Pubmed]   
5. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, et al. Free radical activity and haemostatic factors in NIDDM patients with and without microalbuminuria Diabetes. 1992;41:909-913. [DOI via Crossref]    [Pubmed]   
6. Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH. Tissue factor pathway inhibitor and other endothelium-dependent haemostatic factors in elderly individuals with normal and impaired glucose tolerance and type 2 diabetes. Diabetes Care. 2002;25:1340-5. [DOI via Crossref]    [Pubmed]   
7. Xiang GD, Wang YL. Regular aerobic exercise training improves endothelium-dependent arterial dilation in patients with impaired fasting glucose. Diabetes Care. 2004;27:801-2. [DOI via Crossref]   
8. DeVan AE, Eskurza I, Pierce GL, Walker AE, Jablonski KL, Kaplon RE, et al. Regular aerobic exercise protects against impaired fasting plasma glucose-associated vascular endothelial dysfunction with aging. Clin Sci (Lond). 2013;124:325-31. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
9. Ross R. The pathogenesis of atherosclerosis: a prospective for the 1990s. Nature. 1993;362:801-9. [DOI via Crossref]    [Pubmed]   
10. Safar ME, Henry O, Meaume S. Aortic pulse wave velocity: an independent marker of cardiovascular risk Am J Geriatr Cardiol. 2002;11:295-8. [DOI via Crossref]    [Pubmed]   
11. Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens. 2001;19:381-7. [DOI via Crossref]    [Pubmed]   
12. Naidu MU, Reddy BM, Yashmaina S, Patnaik AN, Rani PU. Validity and reproducibility of arterial pulse wave velocity measurement using new device with oscillometric technique: a pilot study. Biomed Eng online. 2005;4:49. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
13. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, et al. Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb. 2010;17:658-5. [DOI via Crossref]    [Pubmed]   
14. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25:359-64. [DOI via Crossref]    [Pubmed]   
15. Azcutia V, Abu-Taha M, Romacho T, Vázquez-Bella M, Matesanz N, Luscinskas FW, et al. Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo. PLoS One. 2010;5: e10091. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
16. Kelly R, Hayward C, Avolio A, O’Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80:1652-9. [DOI via Crossref]    [Pubmed]   
17. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111-7. [DOI via Crossref]    [Pubmed]   
18. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects 470 years of age. Arterioscler Thromb Vasc Biol. 2001;21:2046-50. [DOI via Crossref]    [Pubmed]   
19. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol. 2001;12:2117-24. [Pubmed]   
20. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434-9. [DOI via Crossref]    [Pubmed]   
21. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106:2085-90. [DOI via Crossref]    [Pubmed]   
22. Mitsutake R, Miura S, Saku K. Association between coronary artery calcification score as assessed by multi-detector row computed tomography and upstroke time of pulse wave. Intern Med. 2007;46:1833-6. [DOI via Crossref]    [Pubmed]   
23. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno and Sobetsu study. Diabetes Care. 2003;26: 437-40. [DOI via Crossref]    [Pubmed]   
24. Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, et al. Impaired fasting glucose: how low should it go? Diabetes Care. 2000;23:34-9. [DOI via Crossref]    [Pubmed]   
25. Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res. 2002;25:351-8. [DOI via Crossref]    [Pubmed]   
26. Lukich E, Matas Z, Boaz M, Shargorodsky M. Increasing derangement of glucose homeostasis is associated with increased arterial stiffness in patients with diabetes, impaired fasting glucose and normal controls. Diabetes Metab Res Rev. 2010;26:365-70. [DOI via Crossref]    [Pubmed]   
27. Ando T, Okada S, Niijima Y, Hashimoto K, Shimizu H, Tsuchiya T, et al. Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early-stage atherosclerosis. Diabet Med. 2010;27:1430-5. [DOI via Crossref]    [Pubmed]   

How to Cite this Article
Pubmed Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo. Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose. Natl J Physiol Pharm Pharmacol. 2016; 6(3): 187-190. doi:10.5455/njppp.2016.6.16122015103


Web Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo. Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose. https://www.njppp.com/?mno=211212 [Access: June 02, 2022]. doi:10.5455/njppp.2016.6.16122015103


AMA (American Medical Association) Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo. Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose. Natl J Physiol Pharm Pharmacol. 2016; 6(3): 187-190. doi:10.5455/njppp.2016.6.16122015103



Vancouver/ICMJE Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo. Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose. Natl J Physiol Pharm Pharmacol. (2016), [cited June 02, 2022]; 6(3): 187-190. doi:10.5455/njppp.2016.6.16122015103



Harvard Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo (2016) Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose. Natl J Physiol Pharm Pharmacol, 6 (3), 187-190. doi:10.5455/njppp.2016.6.16122015103



Turabian Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo. 2016. Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose. National Journal of Physiology, Pharmacy and Pharmacology, 6 (3), 187-190. doi:10.5455/njppp.2016.6.16122015103



Chicago Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo. "Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose." National Journal of Physiology, Pharmacy and Pharmacology 6 (2016), 187-190. doi:10.5455/njppp.2016.6.16122015103



MLA (The Modern Language Association) Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo. "Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose." National Journal of Physiology, Pharmacy and Pharmacology 6.3 (2016), 187-190. Print. doi:10.5455/njppp.2016.6.16122015103



APA (American Psychological Association) Style

Hemamalini Ramasamy Vajravelu, Arpita Priyadarshini, Prabhavathi Krishnan, Saravanan Ayyavoo (2016) Usefulness of pulse wave velocity as an indicator of atherosclerosis in subjects with impaired fasting glucose. National Journal of Physiology, Pharmacy and Pharmacology, 6 (3), 187-190. doi:10.5455/njppp.2016.6.16122015103